Company intelligence / Profile preview

IntegraGen

Évry, Île-de-France, Franceintegragen.com ↗
Ownership
Public · ALINT
Employees
~44
Development stage
Commercial
01

Overview

IntegraGen specializes in providing next-generation sequencing (NGS), molecular diagnostics based on novel genetic biomarkers, and advanced bioinformatics analyses. The company focuses on oncology, rare genetic diseases, autism spectrum disorders, and metabolic conditions. It operates one of France’s largest NGS labs with CAP accreditation and CLIA certification as of late 2023/early 2024. In recent years it has become part of OncoDNA Group. Revenue was €11.8 million in FY2023 with approximately 42–46 employees. IntegraGen serves academic researchers as well as biopharma/CRO clients across Europe.

Therapeutic areas
Rare DiseasesOncologyPsychiatryMetabolic Disorders
Modalities
Diagnostic test (Molecular diagnostic)Genomic analysis service (Next-generation sequencing)Bioinformatics analysis service
Industry
Molecular Diagnostics
02

Partnerships

Academic research institutesBiopharmaceutical companiesContract research organizations (CROs)
03

Financials

Market cap
$301.3M
Total revenue
$80.8M
Enterprise value
$361.5M

Beyond the preview

Go deeper on IntegraGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IntegraGen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call